版本:
中国

BRIEF-Newlink reports Results from clinical trial of indoximod plus chemotherapy

June 2 Newlink Genetics Corp:

* Results from clinical trial of indoximod plus chemotherapy for patients with metastatic breast cancer

* Newlink Genetics Corp - ‍top line data from study show that trial did not meet its pre-specified endpoints​

* Newlink Genetics Corp - ‍results from a phase 2 trial of indoximod in combination with taxane chemotherapy for patients with metastatic breast cancer​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐